Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
about
Applications of CYP450 testing in the clinical settingClinical use of pharmacogenomic tests in 2009The pharmacogenomics of pain management: prospects for personalized medicinePharmacogenetics and anaesthesia: the value of genetic profilingNeonatal pain management: still in search for the Holy GrailCodeine and Morphine MetabolismClinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine?Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version.Pharmacogenetics and individualizing drug treatment during pregnancy.SOGC clinical practice guidelines: Substance use in pregnancy: no. 256, April 2011.Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancyRestricting cough and cold medicines in children.Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeDifferences between opioids: pharmacological, experimental, clinical and economical perspectivesPharmacogenomic considerations in opioid analgesia.Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.Recent advances in the use of opioids for cancer painBaby boy blue - why is this newborn lethargic?A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.Copy number variants in pharmacogenetic genes.Maternal-fetal and neonatal pharmacogenomics: a review of current literature.Clinically relevant genetic variations in drug metabolizing enzymes.Sedating drugs and breastfeeding.Using pharmacogenetics to understand adverse drug reactions in children.Personalised medicine in paediatrics: individualising treatment in children with rare neurological diseases.Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) - short version.Role of cytochrome P450 genotype in the steps toward personalized drug therapy.Pharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug?Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.Postpartum substance use and depressive symptoms: a review.Pharmacogenetic testing: Current Evidence of Clinical Utility.Pharmacogenetics in clinical pediatrics: challenges and strategies.Guidelines for maternal codeine use during breastfeeding.Pharmacogenetics in reproductive and perinatal medicine.Personalized therapy in pain management: where do we stand?Pharmacogenetics and human genetic polymorphisms.Pharmacogenomics and active surveillance for serious adverse drug reactions in children.Demonstrating utility of pharmacogenetics in pediatric populations: methodological considerations.Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers.
P2860
Q24621760-732CBAB9-5D5E-4743-9DC6-395DCC9A6CCFQ24657536-A2C0ED7C-9B65-479B-B32D-DE84F43DA0CBQ26765266-695D6CF5-6188-4A88-8528-8EF4E60FF3AFQ26859221-9147828F-D1BF-4A0E-B4E4-B88E111A20ADQ28078751-DC9A19EA-B388-4AD8-8154-2A087A1DA8B9Q30230768-E072640F-A62A-49A6-8535-D9822DBE376EQ33626990-C51065EA-868F-4FCB-87EE-5A7A8AAFD854Q33696421-AA4912BB-E7E1-44B0-90FA-647C723F88AEQ33781272-B767CDBD-EBD0-4F54-8C93-A68FFE389AABQ34003615-229B7F2A-53B6-4474-880A-C59D9AB67982Q34078458-358AC908-EFCB-442C-BACB-D39551452286Q34123897-36779BCB-D0A7-4059-9223-B2F8C016026CQ34165511-E979F351-2C34-4EED-8823-57E22A13170CQ34243414-DE3B2875-1674-447F-B4BC-E51CAA4498EBQ34272502-A6E0DD5E-E766-4FFA-99A6-65E651933917Q34316700-A3F2AE6D-740F-45F8-A170-E2BC8FE88227Q34399802-4949D26E-2EF3-4594-B6E7-922484F81F40Q34418203-27AA8A3A-8B02-46D6-B4D1-18170853D737Q34437058-28EA59A4-9C2C-46D7-973E-93236EE4653EQ34905699-92CCEEFD-84A6-41A1-83F2-8CF4C1CC30A0Q34975631-69FD59C0-C6A4-41CA-991F-093AFBB93039Q34994866-94FE6172-EB6F-4F42-ABDD-335C66AC2705Q35032378-92C371A2-0709-4D07-88F2-9BCDFC0344E8Q35206016-471842B3-FD52-425C-A499-0B93497A34DEQ35572602-745399F1-0802-4BCD-A9E4-BFE2C1D9F20AQ36117928-1C0B002F-BE1B-4AC1-8250-62778810ED20Q36282065-E2AEE470-B601-44B4-923A-2D536FE4577DQ36441521-ED6E616E-91CF-408C-8CA2-991FA09E0EABQ36562965-DF84CBC4-1B57-4532-B67D-BBE9A1CAE5C1Q36810933-4E242E92-EB70-40A1-AC34-260A3E63D348Q37092322-EABC489F-5A65-49E3-BDDD-D219BE601B32Q37151528-F1ED2C25-13C1-4ACA-A8EF-A19763919870Q37400384-87588C0B-78A1-440C-8FCC-33299B8BE3EFQ37419914-FA3F7E53-B531-4E6B-9AF7-CBD6A94E8E8AQ37657531-730682DC-E4DC-4898-AE1C-238FA7865D42Q37760955-CB79FB70-5CEA-452C-AFC5-1924AF0408E2Q37772183-DBF0F014-992D-481F-954E-2E170376D3ACQ37791154-8FA57CF1-661D-4AD5-A1B0-73678E590447Q37809965-8C649134-64BA-4C7E-ABDD-070F4229E0A9Q37809966-340C363C-3FD0-4DF6-B50E-9F53B898509D
P2860
Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pharmacogenetics of neonatal o ...... feeding: a case-control study.
@en
Pharmacogenetics of neonatal o ...... feeding: a case-control study.
@nl
type
label
Pharmacogenetics of neonatal o ...... feeding: a case-control study.
@en
Pharmacogenetics of neonatal o ...... feeding: a case-control study.
@nl
prefLabel
Pharmacogenetics of neonatal o ...... feeding: a case-control study.
@en
Pharmacogenetics of neonatal o ...... feeding: a case-control study.
@nl
P2093
P2860
P50
P356
P1476
Pharmacogenetics of neonatal o ...... feeding: a case-control study.
@en
P2093
P2860
P356
10.1038/CLPT.2008.157
P407
P577
2008-08-20T00:00:00Z